Skip to main content

Evaluation of the Efficacy of Pharmacotherapy for Decompensated Intestinal Dysbacteriosis in Cats

  • Conference paper
  • First Online:
XV International Scientific Conference “INTERAGROMASH 2022” (INTERAGROMASH 2022)

Abstract

The treatment of intestinal dysbiosis in animals remains one of the most complex and urgent problems in veterinary medicine to this day. Recently, a steady increase in pathologies has been recorded, accompanied by the development of disorders of the gastrointestinal tract of various etiologies in animals. Despite the constant improvement of methods for correcting the intestinal microbiota, the occurrence of dysbacteriosis in various pathological processes not only does not decrease, but, on the contrary, increases. Therefore, the choice of the optimal therapeutic regimen for the correction of the most severe decompensated degree of intestinal dysbacteriosis in cats is an important area of scientific research. The article shows that in case of decompensated intestinal dysbacteriosis in cats, the administration of the probiotic “Lactobifadol” in combination with the prebiotic “Vetelact” and the immunomodulator “Azoksivet” against the background of infusion therapy is the most effective, as evidenced by the registration of an overall clinical improvement of 1.28 times (p < 0.001) faster, when compared with animals of the group C1. At the same time, normalization of appetite, unpleasant odor from the oral cavity and the nature of fecal matter occurs in cats of group C3 1.40 days (p < 0.05), 1.60 days (p < 0.01) and 1.80 days (p < 0.01) earlier, according to compared with animals that were corrected according to scheme C1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rudenko, P.A., Murashev, A.N.: Technological process of integrated probiotics sorption drugs «Dilaksil» and «Sorbelact». Russ. J. Biopharm. 9(3), 49–54 (2017)

    Google Scholar 

  2. McLeish, S.A., Burt, K., Papasouliotis, K.: Analytical quality assessment and method comparison of immunoassays for the measurement of serum cobalamin and folate in dogs and cats. J. Vet. Diagn. Invest. 31(2), 164–174 (2019)

    Article  Google Scholar 

  3. Rudenko, P., Vatnikov, Y., Sachivkina, N., et al.: Search for promising strains of probiotic microbiota isolated from different biotopes of healthy cats for use in the control of surgical infections. Pathogens 10(6), 667 (2021)

    Article  Google Scholar 

  4. Pilla, R., Suchodolski, J.S.: The gut microbiome of dogs and cats, and the influence of diet. Vet. Clin. North Am. Small Anim. Pract. 51(3), 605–621 (2021)

    Article  Google Scholar 

  5. Rudenko, P., Vatnikov, Y., Kulikov, E., et al.: Experimental and clinical justification of the use of probiotic-sorption drugs in veterinary surgery. Syst. Rev. Pharm. 11(4), 275–287 (2020)

    Google Scholar 

  6. Moon, C.D., Young, W., Maclean, P.H., et al.: Metagenomic insights into the roles of Proteobacteria in the gastrointestinal microbiomes of healthy dogs and cats. Microb. Open 7(5), e00677 (2018)

    Article  Google Scholar 

  7. Rudenko, P., Vatnikov, Y., Engashev, S., et al.: The role of lipid peroxidation products and antioxidant enzymes in the pathogenesis of aseptic and purulent inflammation in cats. J. Adv. Vet. Anim. Res. 8(2), 210–217 (2021)

    Article  Google Scholar 

  8. Older, C.E., Gomes, M.O.S., Hoffmann, A.R., et al.: Influence of the FIV status and chronic gingivitis on feline oral microbiota. Pathogens 9(5), 383 (2020)

    Article  Google Scholar 

  9. Rudenko, P.A., Murashev, A.N.: Technological process of integrated probiotics sorption drugs «Dilaksil» and «Sorbelact». Russ. J. Biopharm. 9(6), 40–45 (2017)

    Google Scholar 

  10. Palikov, V.A., Palikova, Y.A., Borozdina, N.A., et al.: A novel view of the problem of osteoarthritis in experimental rat model. Res. Res. Pharm. 6(2), 19–25 (2020)

    Article  Google Scholar 

  11. Rudenko, P., Sachivkina, N., Vatnikov, Y., et al.: Role of microorganisms isolated from cows with mastitis in Moscow region in biofilm formation. Vet. World 14(1), 40–48 (2021)

    Article  Google Scholar 

  12. Vatnikov, Yu., Yousefi, M., Engashev, S., et al.: Clinical and hematological parameters for selecting the optimal dose of the phytopreparation “Deprim”, containing an extract of the herb Hypericum perforatum L. in husbandry. Int. J. Pharm. Res. 12(S.1), 2731–2742 (2020)

    Google Scholar 

  13. Rudenko, A., Rudenko, P., Glamazdin, I., et al.: Assessment of respiratory rate in dogs during the sleep with mitral valve endocardiosis, complicated by congestive heart failure syndrome: the degree of adherence for this test by animal owners and its impact on patient survival. Syst. Rev. Pharm. 11(5), 358–367 (2020)

    Google Scholar 

  14. Vatnikov, Y., Shabunin, S., Karamyan, A., et al.: Antimicrobial activity of Hypericum Perforatum L. Int. J. Pharm. Res. 12(S.1), 723–730 (2020)

    Google Scholar 

  15. Vatnikov, Y., Shabunin, S., Kulikov, E., et al.: Effectiveness of biologically active substances from Hypericum Perforatum L. in the complex treatment of purulent wounds. Int. J. Pharm. Res. 12(4), 1108–1117 (2020)

    Google Scholar 

  16. Rudenko, P., Rudenko, V., Vatnikov, Y., et al.: Diagnostics of unfavorable factors in the cows infection of farms in the Moscow region. Syst. Rev. Pharm. 11(5), 347–357 (2020)

    Google Scholar 

  17. Schmidt, T.S.B., Raes, J., Bork, P.: The human gut microbiome: from association to modulation. Cell 172(6), 1198–1215 (2018)

    Article  Google Scholar 

  18. Peirce, J.M., Alviña, K.J.: The role of inflammation and the gut microbiome in depression and anxiety. Neurosci. Res. 97(10), 1223–1241 (2019)

    Article  Google Scholar 

  19. Trukhachev, V.I., Chikindas, M.L., Bren, A.B., et al.: Probiotic biomarkers and models upside down: from humans to animals. Vet. Microbiol. 261, 109156 (2021)

    Article  Google Scholar 

  20. Durack, J., Lynch, S.V.: The gut microbiome: relationships with disease and opportunities for therapy. J. Exp. Med. 216(1), 20–40 (2019)

    Article  Google Scholar 

  21. Mohajeri, M.H., La Fata, G.G., Steinert, R.E., Weber, P.: Relationship between the gut microbiome and brain function. Nutr Rev. 76(7), 481–496 (2018)

    Article  Google Scholar 

  22. Vatnikov, Yu., Donnik, I., Kulikov, E., et al.: Effectiveness of Hypericum Perforatum L. phytosorbent as a part of complex therapy for acute non-specific bronchopneumonia. Int. J. Pharm. Res. 12(S.1), 1108–1116 (2020)

    Google Scholar 

  23. Vatnikov, Yu., Donnik, I., Kulikov, E., et al.: Research on the antibacterial and antimycotic effect of the phytopreparation Farnesol on biofilm-forming microorganisms in veterinary medicine. Int. J. Pharm. Res. 12(S.2), 1481–1492 (2020)

    Google Scholar 

  24. Kathrani, A., Fascetti, A.J., Larsen, J.A., et al.: Whole-blood taurine concentrations in cats with intestinal disease. J. Vet. Intern. Med. 31(4), 1067–1073 (2017)

    Article  Google Scholar 

  25. Summers, S.C., Quimby, J.M., Isaiah, A., et al.: The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease. J. Vet. Intern. Med. 33(2), 662–669 (2019)

    Article  Google Scholar 

  26. Weersma, R.K., Zhernakova, A., Fu, J.: Interaction between drugs and the gut microbiome. Gut 69(8), 1510–1519 (2020)

    Article  Google Scholar 

  27. Ochoa-Repáraz, J., Kirby, T.O., Kasper, L.H.: The Gut microbiome and multiple sclerosis. Cold Spring Harb. Perspect. Med. 8(6), a029017 (2018)

    Google Scholar 

  28. Tizard, I.R., Jones, S.W.: The microbiota regulates immunity and immunologic diseases in dogs and cats. Vet. Clin. North Am. Small. Anim. Pract. 48(2), 307–322

    Google Scholar 

  29. Vatnikov, Yu., Shabunin, S., Kulikov, E., et al.: The efficiency of therapy the piglets gastroenteritis with combination of Enrofloxacin and phytosorbent Hypericum Perforatum L. Int. J. Pharm. Res. 12(S.2), 3064–3073 (2020)

    Google Scholar 

  30. Sidhu, M., van der Poorten, D.: The gut microbiome. Aust. Fam. Physician 46(4), 206–211 (2017)

    Google Scholar 

  31. Wosinska, L., Cotter, P.D., O’Sullivan, O., Guinane, C.: The potential impact of probiotics on the gut microbiome of athletes. Nutrients 11(10), 2270 (2019)

    Article  Google Scholar 

  32. Marsilio, S., Pilla, R., Sarawichitr, R., et al.: Characterization of the fecal microbiome in cats with inflammatory bowel disease or alimentary small cell lymphoma. Sci. Rep. 9(1), 19208 (2019)

    Article  Google Scholar 

  33. Alessandri, G., Argentini, C., Milani, C., et al.: Catching a glimpse of the bacterial gut community of companion animals: a canine and feline perspective. Microb. Biotechnol. 13(6), 1708–1732 (2020)

    Article  Google Scholar 

  34. Suchodolski, J.S.: Diagnosis and interpretation of intestinal dysbiosis in dogs and cats. Vet. J. 215, 30–37 (2016)

    Article  Google Scholar 

  35. Honneffer, J.B., Minamoto, Y., Suchodolski, J.S.: Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs. World J. Gastroenterol. 20(44), 16489–16497 (2014)

    Article  Google Scholar 

  36. Popov, I.V., Prazdnova, E.V., Mazanko, M.S., et al.: A review of the effects and production of spore-forming probiotics for poultry. Animals 11(7), 1941 (2021)

    Article  Google Scholar 

  37. Bugrov, N., Rudenko, P., Lutsay V,l, et al.: Fecal microbiota analysis in cats with intestinal dysbiosis of varying severity. Pathogens 11(2), 234 (2022)

    Article  Google Scholar 

  38. Tazehabadi, M.H., Algburi, A., Popov, I.V., et al.: Probiotic Bacilli ingibit Salmonella biofilm formation without killing planktonic cells. Front. Microbiol. 12, 615328 (2021)

    Google Scholar 

  39. Tiwari, S.K., Dicks, L.M.T., Popov, I.V., et al.: Probiotics at war against viruses: what is missing from the picture? Front. Microbiol. 11, 1877 (2020)

    Google Scholar 

  40. Whittemore, J.C., Stokes, J.E., Price, J.M., Suchodolski, J.S.: Effects of a synbiotic on the fecal microbiome and metabolomic profiles of healthy research cats administered clindamycin: a randomized, controlled trial. Gut Microbes 10(4), 521–539 (2019)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergey Tresnitskiy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Rudenko, P., Bugrov, N., Tresnitskiy, S., Lenchenko, E., Subbotina, Y., Blumenkrants, D. (2023). Evaluation of the Efficacy of Pharmacotherapy for Decompensated Intestinal Dysbacteriosis in Cats. In: Beskopylny, A., Shamtsyan, M., Artiukh, V. (eds) XV International Scientific Conference “INTERAGROMASH 2022”. INTERAGROMASH 2022. Lecture Notes in Networks and Systems, vol 575. Springer, Cham. https://doi.org/10.1007/978-3-031-21219-2_68

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-21219-2_68

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-21218-5

  • Online ISBN: 978-3-031-21219-2

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics